课题基金 / 基金详情

Structure of upregulated VLA-4 antigen expressed on PBL from SLE

Structure of upregulated VLA-4 antigen expressed on PBL from SLE
SLE PBL 上表达上调的 VLA-4 抗原的结构
批准号:
05670430
负责人:
TAKEUCHI Tsutomu
金额:
$1.28万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1993
资助国家:
日本
项目状态:
已结题
起止时间:
1993 至 1994

项目摘要

项目成果

TAKEUCHI Tsutomu的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Structure of VLA-4 antigen expressed on SLE T cellsIn patients with SLE complicated with vasculitis, it has been demonstrated that expressions of not only LFA-1, but also VLA-4 were upregulated. Moreover, the additional high molecular weight band migrating at 180 kD of VLA-4 was obaerved in SLE with vasculitis, whereas 140 kD normal VLA-4 was detected in normal individual and SLE without vasculitis.Adhesion function and signal transduction via VLA-4 in SLE with vasculitisPeripheral T cells frpm SLE with vasculitis showed elevated adherence to fibronectin and VCAM-1. After adhesito VLA-4 ligands, ca influx was observed in these T cells, suggesting that this elicited the signal into the cell interior.Signal transduction through functionally activated VLA-4 in SLE with vasculitisWe next examined the molecular interaction of signal transduction through VLA-4 in these fn these patients in which expression as well as function was upregulated. Given the evidences that intgrins trnasmit signals by binding to cytoskeltal proteins and forming mocal adhesion, talin, one of these cytoskeltal proteins which can binds to cytoplasmic domain of integrin beta chian were observed by Adherent Cell Analyzing System (ACAS) equipped with confocal optical system. We found that focal adhesion and the expression of talin were observed of unstimulated SLE T cells adhered onto fibronectin, whereas those of normal T cells were not. At same time, strong tyrosine-phosphorylation was noted adaround those focal adhesions, suggesting that these signal transduction pathways through intgrins were functionally activated and strongly expressed in T cells from SLE with vasculitis.
期刊论文(58)
专著(0)
科研奖励(0)
会议论文
Takeuchi,T.,et al: "Characterization of AE-6 monoclonal antibody recognizing VHCSAGV sequence in CD45 DTPase domain." Tissue Antigens. 42. 441 (1993)
Takeuchi,T.,et al:“识别 CD45 DTPase 结构域中 VHCSAGV 序列的 AE-6 单克隆抗体的表征。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Takeuchi,T.,et al: "Intractable vasculitis syndrome" Tanabe,T.and Yoshiki,T.eds,Hokkaido Univ.Press,Sapporo., 284 (1993)
Takeuchi,T.,et al:“难治性血管炎综合征”Tanabe,T.and Yoshiki,T.eds,Hokkaido Univ.Press,Sapporo.,284 (1993)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Takeuchi, T, et al: "Enhanced expression of pp125FAKin peripheral T cells in patients with systemic lupus erythematosus" Arth Rheum. 37. 5377- (1994)
Takeuchi, T 等人:“系统性红斑狼疮患者外周 T 细胞中 pp125FAK 的表达增强”Arth Rheum。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Takeuchi T,Sekine H,Saito K,Koide J,Mori S,and Abe T.: "Focal adhesion kinase pp125FAK is highly expressed in the peripheral blood lymphocytes on patients systemic lupus erythematosus complicated with vasculitis." (submitted for publication.).
Takeuchi T、Sekine H、Saito K、Koide J、Mori S 和 Abe T.:“粘着斑激酶 pp125FAK 在系统性红斑狼疮并发血管炎患者的外周血淋巴细胞中高表达。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
30
    Molecular signatures in pre-RA patients by multi-omics analysis
    • 批准号:
      20H03720
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.4万
    • 财政年份:
      2020
    • 负责人:
      TAKEUCHI Tsutomu
    • 依托单位:
    Identification and characterization of pathogenesis related molecules in early rheumatoid arthritis by DNA microarray
    • 批准号:
      23390259
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.31万
    • 财政年份:
      2011
    • 负责人:
      TAKEUCHI Tsutomu
    • 依托单位:
    Analysis on signal transduction pathway through CD103 molecule
    • 批准号:
      20591193
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.0万
    • 财政年份:
      2008
    • 负责人:
      TAKEUCHI Tsutomu
    • 依托单位:
    Construction of a galaxy SED model consistent with chemical evolution
    • 批准号:
      20740105
    • 项目类别:
      Grant-in-Aid for Young Scientists (B)
    • 资助金额:
      $1.91万
    • 财政年份:
      2008
    • 负责人:
      TAKEUCHI Tsutomu
    • 依托单位:
    国内基金
    海外基金
    阻断LFA-1/VLA-4通路抑制CAR-T细胞中靶脱瘤毒性并增强T细胞记忆功能的机制研究
    • 批准号:
      82373249
    • 项目类别:
      面上项目
    • 资助金额:
      48万元
    • 批准年份:
      2023
    • 负责人:
      翟博
    • 依托单位:
    从DLI探索靶向干预VLA-4促进Allo-HSCT后HSC植入的作用及机制
    • 批准号:
      --
    • 项目类别:
      面上项目
    • 资助金额:
      52万元
    • 批准年份:
      2022
    • 负责人:
      宋献民
    • 依托单位:
    VLA-4 基因表达的调控及其在骨髓瘤抗药性中的作用
    • 批准号:
      81071743
    • 项目类别:
      面上项目
    • 资助金额:
      31.0万元
    • 批准年份:
      2010
    • 负责人:
      李志伟
    • 依托单位:
    黏附分子VLA-4等在HFRS免疫发病机制中作用的初步研究
    • 批准号:
      30740021
    • 项目类别:
      专项基金项目
    • 资助金额:
      10.0万元
    • 批准年份:
      2007
    • 负责人:
      谢明
    • 依托单位: